From October 28 to 30. 2025. the global pharmaceutical industry's annual flagship event—CPHI Frankfurt 2025—successfully concluded at the Frankfurt International Exhibition Center. As a professional exhibition covering the entire industry chain, including active pharmaceutical ingredients, pharmaceutical equipment, and contract manufacturing, this year's event attracted approximately 2.400 exhibitors and over 60.000 pharmaceutical professionals from around the world. Laviana Pharma made a remarkable appearance with its one-stop CDMO services.

​Recently, Fu Huidong, Chairman of the Hebei Provincial Federation of Returned Overseas Chinese, Wang Jingchao, Secretary of the Cangzhou Federation of Returned Overseas Chinese, and Cheng Xiuzhen, Member of the Party Working Committee of Cangzhou Bohai New Area, Standing Committee Member of Huanghua Municipal Committee, and Minister of the United Front Work Department, along with other departmental leaders, visited Laviana Pharma (Cangzhou) Co., Ltd. for research. They focused on examining the company's innovative achievements in pharmaceutical R&D, intelligent manufacturing, and green processes. Chen Wenting, Chairman of Laviana Pharma, Jin Jing, General Manager of the Cangzhou company, and Guo Weitao, Executive Vice President, accompanied the visit and engaged in in-depth discussions on international development.

Recently, one of the most influential professional media in the international pharmaceutical technology field, "Pharma Tech Outlook," officially announced the annual list of "TOP PRECLINICAL RESEARCH SERVICES 2025." Laviana Pharma stood out from global candidates due to its strong foundation, innovative breakthroughs, and excellent customer reputation in the field of preclinical research services, winning the award.

Recently, to strengthen safety production management and improve the emergency response capabilities of all employees, the Laviana Pharma Cangzhou GMP production base organized a comprehensive emergency drill in multiple scenarios. This drill simulated various emergencies such as fire, earthquake, and power outage, covering key areas including the office area, production workshop, and tank area. The aim was to test the feasibility of the emergency plan and enhance employees' emergency response levels.

Recently, Li Hong, Vice Chairman of the Tianjin Municipal People's Congress Standing Committee, and his delegation visited Laviana Pharma (Tianjin) Co., Ltd. for a special research study. Mr. Chen Wenthing, Chairman of Laviana Pharma, and Dr. Yang Guang, Chief Scientific Officer, attended and introduced the company's development situation. The purpose of this research is to further promote the implementation of the "Tianjin Municipal Regulations on the Protection of the Rights and Interests of Overseas Chinese," to legally protect the legitimate rights and interests of overseas Chinese, and to gain an in-depth understanding of the development status of overseas Chinese-funded enterprises, providing support and assistance for their development. Officials from the Municipal People's Congress Ethnic and Religious Affairs Committee, Municipal People's Congress representatives, Municipal Overseas Chinese Affairs Office, Municipal Overseas Chinese Federation, Municipal Overseas Chinese Chamb

In order to thoroughly implement the requirements for safety production deployment and to comprehensively enhance the safety awareness and emergency response capabilities of all employees, since June, Laviana Pharma has closely focused on the theme of "Everyone Talks About Safety, Everyone Knows Emergency Response". It has carefully planned and organized a series of diverse and content-rich activities for "Safety Production Month", laying a solid safety foundation for the company's stable operation.